New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
11:05 EDTFTNT, EWT, ECA, ROYL, WLB, VRS, TXMD, SHPGHigh option volume stocks:
High option volume stocks: ININ FTNT EWT ECA SOCL ROYL WLB VRS TXMD SHPG
News For FTNT;EWT;ECA;ROYL;WLB;VRS;TXMD;SHPG From The Last 14 Days
Check below for free stories on FTNT;EWT;ECA;ROYL;WLB;VRS;TXMD;SHPG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 23, 2014
16:42 EDTFTNTFortinet sees Q3 EPS 11c, consensus 13c
Subscribe for More Information
16:32 EDTFTNTFortinet reports Q2 adjusted EPS 11c, consensus 10c
Subscribe for More Information
13:34 EDTECAEncana August calls active into Q2 and outlook
Subscribe for More Information
13:28 EDTFTNTCheck Point advances after results beat expectations
Subscribe for More Information
12:57 EDTFTNTCheck Point Q2 results, guidance solid, says Wells Fargo
Wells Fargo believes that Check Point (CHK) reported solid Q2 results and provided solid guidance, as its large deal metrics were particularly strong, according to Wells. The firm thinks the results show that spending trends in cyber security remain strong, boding well for cyber security companies Palo Alto (PANW), Fortinet (FTNT), and FireEye (FEYE). Wells keeps an Outperform rating on Check Point.
11:21 EDTSHPGOptions with decreasing implied volatility
Options with decreasing implied volatility: INO SHPG IRBT CMG LXK PSEC CROX ATHN VMW
11:08 EDTFTNTHigh option volume stocks
Subscribe for More Information
09:36 EDTECAEncana upgraded to Hold from Sell at Tudor Pickering
Subscribe for More Information
07:28 EDTSHPGShire enters licensing and collaboration agreement with ArmaGen
Shire and ArmaGen, a US privately held biotechnology company, announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy for the potential treatment of both the central nervous system and somatic manifestations in patients with Hunter syndrome. Shire will obtain worldwide commercialization rights for AGT-182 in exchange for payments of approximately $225M to ArmaGen, including an initial upfront payment of $15M in cash and equity, an additional equity investment, R&D funding, development milestones and sales milestones, in addition to royalty payments. ArmaGen will be responsible for conducting and completing the Phase I/II study which it expects to initiate before the end of 2014, after which point Shire will be responsible for further clinical development, including Phase III trials, and commercialization.
06:01 EDTSHPGStocks with implied volatility below IV index mean; INTC SHPG
Stocks with implied volatility below IV index mean; Intel (INTC) 18, Shire (SHPG) 19 according to iVolatility.
July 22, 2014
14:08 EDTECAEarnings Preview: Freeport McMoRan sentiment positive ahead of Q2 report
Subscribe for More Information
10:48 EDTSHPGOptions with decreasing implied volatility
Options with decreasing implied volatility: IGT YHOO LYK ATHN CMG SWKS NFLX SHPG SNDK MTG
05:59 EDTSHPGStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
July 21, 2014
10:27 EDTSHPGUBS pharma and federal affairs analysts hold an analyst/industry conference call
Subscribe for More Information
10:02 EDTSHPGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:50 EDTSHPGShire downgraded to Neutral from Buy at Buckingham
Subscribe for More Information
08:01 EDTSHPGAbbVie acquisition positive, says Argus
Subscribe for More Information
07:59 EDTSHPGShire downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Shire (SHPG) on Friday to Market Perform citing the takeover by AbbVie (ABBV) as it does not expect competitive bids to emerge.
06:51 EDTECAEncana poised to sell Deep Panuke project this year, Bloomberg says
Subscribe for More Information
06:14 EDTSHPGStocks with implied volatility below IV index mean; INTC SHPG
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use